Conductor-Based Radiotracer Delivery for Controlled Biodistribution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current radiotracer labeling and administration methods face challenges in controlling systemic distribution and retention, leading to off-target radiation exposure and limited applications in diagnostic and therapeutic immunomodulation.
Innovation Solution
A conductor-based system for electronically radiolabeling radiotracers via trans-vascular absorption, allowing controlled biodistribution and activation of non-radioactive precursors without intravenous injection, enabling precise, on-demand flexibility for systemic immunomodulation and diagnostic imaging.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional intravenous injection or infusion methods are used to administer radiotracers, then the radiotracer can be delivered into the body, but the systemic distribution is uncontrolled and off-target radiation exposure occurs
Solution Approach 1:
The patent applies dynamics by making the radiotracer administration system adjustable and controllable. The conductor-based system allows dynamic control of radiotracer delivery through electrical connection, enabling on-demand activation and cessation of biodistribution. This dynamic control mechanism resolves the contradiction by providing reliable controlled distribution while minimizing harmful off-target exposure through precise temporal control.
Solution Approach 2:
The patent introduces a conductor as an intermediary between the radiotracer and the vascular system. The conductor serves as a mediator that enables controlled trans-vascular absorption of radiotracers without direct intravenous injection. This intermediary approach provides controlled biodistribution pathways while reducing uncontrolled radiation exposure to off-target tissues.
2Manufacturing precision
If conventional administration methods are used, then radiotracers can be delivered systemically, but precise dose control and reproducibility are limited
Solution Approach 1:
The patent replaces conventional mechanical injection systems with an electrical/conductor-based system for radiotracer administration. This substitution enables more precise dose control through electrical parameters (current, voltage, contact time) while maintaining operational simplicity. The conductor-based system provides reproducible dosing through controlled electrical interaction with the vascular system, resolving the contradiction between precision and complexity.
3Duration of action of moving object
If traditional radiolabeling methods are used, then radiotracers can be labeled, but the labeling process does not enable controlled activation timing
Solution Approach 1:
The patent applies dynamics to activation timing control by using the conductor-based system that can be activated and deactivated at any desired time. The electrical connection to the conductor enables on-demand activation of radiotracer biodistribution, providing precise temporal control over the duration of action. This dynamic control mechanism enhances application flexibility for various diagnostic and therapeutic scenarios.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables reproducible, flexible, and efficient diagnostic and therapeutic applications by ensuring controlled biodistribution and activation of radiotracers, minimizing off-target exposure and expanding applications beyond traditional methods.
Implementation Method 1
trans-vascular absorption of electronically radiolabeled radiotracer(s) via contact with a conductor made of conductive material
Implementation Method 2
electronically radiolabeling of radiotracer(s) by providing a conductive material to facilitate trans-vascular absorption
Data Source
AI summary
Methods are disclosed for electronically labeling and systemically administering radiotracers for targeted diagnostic and therapeutic applications, including immunomodulation. Radiotracers are electronically radiolabeled via direct application to a conductive conductor and delivered systemically through trans-vascular absorption, enabling controlled biodistribution confined to the conductor contact and minimizing off-target exposure. Real-time imaging permits monitoring of radiotracer distribution and activity during administration. Applications include immune modulation for suppression, ablation, or stimulation, as well as activation of non-radioactive precursors for diagnostic and therapeutic use. These methods are applicable to cancer, infectious disease, and autoimmune disorder treatment. Parameters such as radiotracer choice, radioactive activity, precursor formulation, dosing schedule, and administration duration may be adjusted individually or in combination to achieve the desired outcome. These techniques provide reproducible, controllable radiotracer delivery suitable for both imaging and therapy with integrated monitoring.